Difficult-To-Treat Periprosthetic Hip Infection: Outcomes of Debridment

被引:2
|
作者
Liventsov, V. N. [1 ]
Bozhkova, S. A. [2 ,3 ]
Kochish, A. Yu. [4 ]
Artyukh, V. A. [1 ]
Razorenov, V. L. [5 ]
Labutin, D. V. [2 ]
机构
[1] Vreden Russian Res Inst Traumatol & Orthoped, Dept Purulent Surg, St Petersburg, Russia
[2] Vreden Russian Res Inst Traumatol & Orthoped, Res Dept Prevent & Treatment Wound Infect, St Petersburg, Russia
[3] Vreden Russian Res Inst Traumatol & Orthoped, Dept Clin Pharmacol, St Petersburg, Russia
[4] Vreden Russian Res Inst Traumatol & Orthoped, Sci & Educ, St Petersburg, Russia
[5] Vreden Russian Res Inst Traumatol & Orthoped, St Petersburg, Russia
来源
TRAVMATOLOGIYA I ORTOPEDIYA ROSSII | 2019年 / 25卷 / 04期
关键词
difficult-to-treat periprosthetic infection; muscle flap; resection arthroplasty; etiology; stable remission of infection; antimicrobial-loaded cement spacer; PROSTHETIC JOINT INFECTION; LATERALIS MUSCLE FLAP; 2-STAGE REVISION; MANAGEMENT; FAILURE; KNEE;
D O I
10.21823/2311-2905-2019-25-4-88-97
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Purpose of the study - to compare management efficiency for difficult-to-treat periprosthetic hip joint infection (PJI) during resection arthroplasty with grafting by vastus lateralis pedicle island flap in comparison with insertion of an antimicrobial-loaded cement spacer. Material and Methods. 132 patients were included into the retrospective study who underwent treatment from 2012 until 2018 including removal of orthopaedic implant, radical surgical debridement of infection focus, resection arthroplasty with grafting by vastus lateralis pedicle island muscle flap (PMF group - 57 patients) or insertion of antibacterial-loaded cement spacer (AMS group - 75 patients). The authors examined medical histories, nature of infection process, infection agent type, laboratory data in respect of systemic inflammation, size of bone defects, follow up status and remission of PJI in the late period. Results. 89.4% of patients (n = 51) who underwent grafting by vastus lateralis pedicle island flap had a history of 3 and more prior surgical procedures in the same area. At the same time the share of such patients in the spacer group was only 38.6% (n = 29) (p<0.0001) while the share of patients with two and more recurrences was 78.9% (n = 45) and 25.3% (n = 19), respectively (p<0.0001). No significant variances were observed between the groups in respect of type composition of PJI microbial infection agents. The infection in a vast majority of patients in both groups was caused by microbial association: 77.2% and 72.0% in PMF and AMS groups, respectively. In the early postoperative period secondary revision of surgical site was performed in 35% and 28% of cases in PMF group (n = 20) and AMS group (n = 21), respectively, including due to recurrent infection in 15.8% and 28% of cases, respectively. Stable remission of difficult-to-treat PJI in PMF group was 96.5% and 45.3% in AMS group. Conclusion. Despite some cases that required secondary revisions in early postoperative period the resection arthroplasty in combination with pedicle muscle flap can be considered a surgery of choice for management of recurrent difficult-to-treat PJI with feasible re-implantation of prosthesis against the stable remission of infection.
引用
收藏
页码:88 / 97
页数:10
相关论文
共 50 条
  • [31] CHEMOTHERAPEUTIC POSSIBILITIES IN DIFFICULT-TO-TREAT INFECTIONS
    WILLIAMS, JD
    INFECTION, 1980, 8 (06) : 309 - 313
  • [32] An inflamed subtype of difficult-to-treat depression
    Suneson, Klara
    Grudet, Cecile
    Ventorp, Filip
    Malm, Johan
    Asp, Marie
    Westrin, Asa
    Lindqvist, Daniel
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2023, 125
  • [33] Obesity and difficult-to-treat arterial hypertension
    Finer, N.
    CLINICAL OBESITY, 2014, 4 (02) : 59 - 60
  • [34] Innovative approaches for difficult-to-treat populations
    Holloway, F
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 1999, 45 (02) : 150 - 150
  • [35] Innovative approaches for difficult-to-treat populations
    Leonard, D
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1998, 32 (05): : 733 - 733
  • [36] Tanezumab improves difficult-to-treat OA
    Onuora, Sarah
    NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (06) : 296 - 296
  • [37] The challenges of difficult-to-treat Acinetobacter infections
    Richards, Guy A.
    Perovic, Olga
    Brink, Adrian J.
    CLINICAL MICROBIOLOGY REVIEWS, 2024,
  • [38] Manifestations and Management of Difficult-to-Treat Psoriasis
    Aldredge, Lakshi M.
    Higham, Robert C.
    JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION, 2018, 10 (04) : 189 - 197
  • [39] Abrocitinib for difficult-to-treat atopic dermatitis
    Lorenz, Judith
    AKTUELLE DERMATOLOGIE, 2023, 49 (12) : 546 - 546
  • [40] Severe and Difficult-to-Treat Asthma in Adults
    Israel, Elliot
    Reddel, Helen K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (10): : 965 - 976